NYSEMKT: AZTRAzitra Inc Stock
$0.22+0.00 (+0%)
Updated Apr 26, 2024
AZTR Price
$0.22
Fair Value Price
N/A
Market Cap
$6.28M
52 Week Low
$0.16
52 Week High
$5.18
P/E
-0.12x
P/B
2.16x
P/S
9.29x
PEG
N/A
Dividend Yield
N/A
Revenue
$686.00k
Earnings
-$11.28M
Gross Margin
100%
Operating Margin
-1,617.89%
Profit Margin
-1,842.4%
Debt to Equity
0.76
Operating Cash Flow
-$7M
Beta
-0.27
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AZTR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AZTR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AZTR is good value based on its book value relative to its share price (2.16x), compared to the US Biotechnology industry average (5.85x)
P/B vs Industry Valuation
AZTR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AZTR due diligence checks available for Premium users.
Be the first to know about important AZTR news, forecast changes, insider trades & much more!
AZTR News
Valuation
AZTR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.12x
Industry
14.88x
Market
41.14x
AZTR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.16x
Industry
5.85x
AZTR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AZTR's financial health
Profit margin
Revenue
$90.0k
Net Income
-$2.5M
Profit Margin
-2,726.4%
AZTR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AZTR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.1M
Liabilities
$2.2M
Debt to equity
0.76
AZTR's short-term assets ($2.54M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AZTR's short-term assets ($2.54M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AZTR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.6M
Investing
-$60.0k
Financing
$39.1k
AZTR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AZTR vs Biotech Stocks
Azitra Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.